Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective

Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi

Clin Mol Hepatol. 2023;29(2):242-251. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0102

View: 5264 Download: 237 Web of Science: 4 Crossref: 6

4

A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization

Young Kul Jung , Jong Eun Yeon , Chung Ho Kim , Hyun Jung Lee , Young Sun Lee , Eileen L. Yoon , Eun Suck Jung , Jong Hwan Choi , Ji Hoon Kim , Kwan Soo Byun

Clin Mol Hepatol. 2009;15(3):357-361. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.357

View: 6561 Download: 36

3

Incidence and risk factors of acute renal failure after of acute renal failure after transcatheter arterial chemoembolization for hepatocellular carcinoma

Byoung Kuk Jang, M.D., Seung Hyun Lee, M.D., Woo Jin Chung, M.D., Kyung Sik Park, M.D., Kwang Bum Cho, M.D., Jae Seok Hwang, M.D., Young Hwan Kim, M.D. Jin Soo Choi, M.D. Jung Hyeok Kwon, M.D.

Clin Mol Hepatol. 2008;14(2):168-177. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.168

View: 4935 Download: 56 Crossref: 6

4

A Case of Resection of Biloma with Hepatocellular Carcinoma after Embolization

Won Kyu Park, M.D., Jay Chun Chang, M.D., Heon Zu Lee, M.D.*, Hong Jin Kim, M.D.†, Joon Hyuk Choi, M.D.‡, and Mi Jin Gu, M.D.‡

Clin Mol Hepatol. 2002;8(3):331-335. Published online January 1, 2000

View: 2899 Download: 23

Liver Abscess Formation in Non - Tumorous Parenchyma after Transcatheter Arterial Chemoembolization (TACE) for the Treatment of Hepatocellular Carcinoma Associated with Pneumobilia

Yong Kyun Kim, M.D., Su Eun Yu, M.D., Chang Kyun Hong, M.D., Sung Ku Lee, M.D., Young Chul Kim. M.D., So Young Lee, M.D., Si Hyun Bae, M.D., Je Hyun Shin, M.D., Byung Hun Byun, M.D., Jong Young Choi, M.D., Young Min Park, M.D., Kyu Won Chung, M.D., Hee Sik Sun, M.D., Doo Ho Park, M.D., Boo Sung Kim, M.D., Yeon Joo Jung, M.D.†

Clin Mol Hepatol. 2001;7(2):189-194. Published online January 1, 2000

View: 3000 Download: 16

1 |

Viewed By 4990	MAFLD: How is it different from NAFLD?
Viewed By 4840	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4771	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4489	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4438	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search